Product Information
METHAMPHETAMINE 5 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $5.0978 per EA under NDC 00054038925. Its NADAC has been published 227 times since Sep 19, 2018.
FDA first approved this application on Nov 17, 2015. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054038925
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHAMPHETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203846FDA Approved
11/17/2015
TE Code
AA
On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for METHAMPHETAMINE 5 MG TABLET has been published 227 times since Sep 19, 2018, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.0978 per EA |
|---|---|
| All-time high | $6.8723 (Jul 14, 2021) |
| All-time low | $5.0978 (Aug 19, 2026) |
| 52-week high | $6.7520 |
| 52-week low | $5.0978 |
| Median price | $5.9883 |
| Average price | $6.1716 |
| Largest weekly change | +13.8% (May 19, 2021) |
| Weeks tracked | 227 |
| Tracking since | Sep 19, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methamphetamine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methamphetamine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHAMPHETAMINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAMPHETAMINE 5 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $5.0978 per EA (NDC 00054038925), effective Sep 30, 2026.
How has the price of METHAMPHETAMINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAMPHETAMINE 5 MG TABLET has declined 13.1%. It has been tracked across 227 weekly CMS publications since Sep 19, 2018.
What are the highest and lowest recorded NADAC prices for METHAMPHETAMINE 5 MG TABLET?
Since Sep 19, 2018, the NADAC for METHAMPHETAMINE 5 MG TABLET has ranged from a low of $5.0978 (Aug 19, 2026) to a high of $6.8723 (Jul 14, 2021), with a median of $5.9883 per EA.
Are there cheaper alternatives to METHAMPHETAMINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METHAMPHETAMINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHAMPHETAMINE 5 MG TABLET?
METHAMPHETAMINE 5 MG TABLET (NDC 00054038925) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.